Related Experiment Video
Updated: May 21, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Correlation of foot process effacement with clinicopathological features and short-term prognosis in IgA nephropathy
Yu Wang1, Yang Yang1, Xiaoli Wen1
1Department of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Objective:
To compare clinicopathological characteristics and short-term renal outcomes of IgA nephropathy (IgAN) patients with varying degrees of foot process effacement (FPE).
Methods:
This multicenter retrospective study evaluated 1,001 biopsy-proven IgAN patients grouped by FPE severity (mild, moderate, severe). Regression models identified factors associated with different FPE degrees. Short-term outcomes in a 1-year follow-up subset were analyzed using overlap weighting, Cox regression, and Kaplan-Meier analysis.
Results:
The cohort comprised 38.8% mild, 49.6% moderate, and 11.6% severe FPE cases. Greater FPE severity corresponded with elevated blood pressure, proteinuria, and anemia, alongside decreased estimated glomerular filtration rate (eGFR) and albumin levels. Pathologically, worsening FPE correlated with advanced mesangial hyperplasia and tubulointerstitial damage. Severe FPE was distinctively associated with higher serum phosphorus, endocapillary hypercellularity (E1), and progressive interstitial fibrosis (T). Among 486 followed patients, complete remission rates were significantly lower in the severe FPE group than in the mild group (HR = 0.475, p = 0.046).
Conclusions:
The degree of FPE in IgAN was significantly positively correlated with proteinuria, hypoalbuminemia, eGFR decline, mesangial hypercellularity, and tubular atrophy/interstitial fibrosis. Severe FPE is an independent risk factor influencing short-term renal outcomes in IgAN patients.
Insights
Foot process effacement (FPE) severity in IgA nephropathy (IgAN) correlates with worse kidney function and higher risk of poor outcomes. Severe FPE independently predicts worse short-term renal outcomes in IgAN patients.
Area of Science:
- Nephrology
- Pathology
- Clinical Medicine
Background:
- IgA nephropathy (IgAN) is a common primary glomerulonephritis.
- Foot process effacement (FPE) is a key pathological feature in IgAN.
- The clinical significance of varying FPE degrees requires further elucidation.
Purpose of the Study:
- To compare clinicopathological characteristics of IgAN patients with different degrees of FPE.
- To evaluate the association between FPE severity and short-term renal outcomes in IgAN.
Main Methods:
- Retrospective analysis of 1,001 biopsy-proven IgAN patients categorized by FPE severity (mild, moderate, severe).
- Clinical and pathological data were analyzed using regression models.
- Short-term renal outcomes (1-year follow-up) were assessed using overlap weighting, Cox regression, and Kaplan-Meier analysis.
Main Results:
- Higher FPE severity correlated with increased blood pressure, proteinuria, anemia, and decreased eGFR and albumin.
- Worsening FPE was associated with advanced mesangial hyperplasia and tubulointerstitial damage.
- Severe FPE was linked to higher serum phosphorus, endocapillary hypercellularity, and interstitial fibrosis, with significantly lower remission rates.
Conclusions:
- FPE degree in IgAN is significantly correlated with proteinuria, hypoalbuminemia, eGFR decline, and interstitial fibrosis.
- Severe FPE is an independent risk factor impacting short-term renal outcomes in IgAN patients.
More Related Videos
07:02Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
Published on: February 10, 2026
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Diabetic Nephropathy
Nephrotic Syndrome II : Assessment and Medical Management
Diabetic Foot Ulcer
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations